Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Catrix
- Development stage
- Unknown
- Lead developer
- Lescarden
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral, Topical, Ophthalmic
01
Overview
Catrix is a brand name associated with three distinct pharmaceutical products. One formulation is an oral tablet containing **aceclofenac**, a non-steroidal anti-inflammatory drug (NSAID) that preferentially inhibits cyclooxygenase-2 (COX-2) to treat pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. A second product is a topical **bovine cartilage powder** used as a biological dressing for wound healing in pressure ulcers, venous stasis ulcers, diabetic ulcers, and burns; it promotes healing by stimulating the growth of fibroblasts and keratinocytes. A third version is an **ophthalmic solution** containing anhydrous sodium succinate and cytochrome C, developed by Incepta Pharmaceuticals for the treatment of lens opacification (cataracts) by supporting cellular metabolism and providing antioxidant effects.
- Brand names
- Catrix
- Other names
- aceclofenacbovine cartilage powderanhydrous sodium succinate + cytochrome C
02
Targets
CYCS (Cytochrome c)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SDH (Mitochondrial electron transport chain complex II)
Beyond the preview
Go deeper on Catrix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Catrix.